What is the management of secondary polycythemia in patients treated with testosterone?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18868288
Cited by: 0

Abstract

Management of secondary polycythemia in patients on testosterone includes monitoring hematological parameters, adjusting therapy as needed, and possibly using phlebotomy. Identifying and addressing additional health factors is also important.

Fields of Study & Subjects

Erythropoietin and Anemia Treatment Hormonal and reproductive studies Myeloproliferative Neoplasms: Diagnosis and Treatment

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
4 March 2026
Language
EN